Why Fluoride Toothpaste Files as a Drug, Not a Cosmetic
Anticavity and antigingivitis claims put fluoride toothpaste in drug territory, and why that matters if you are branching into oral care.
A soap and skincare maker asked us recently if they could add a natural toothpaste to their lineup and file it the same way they file their lotions. Reasonable question given how similar the process feels on paper, mix ingredients, list them, notify. But toothpaste with fluoride is not going through the Cosmetic Notification System at all. It is regulated as a drug, and the reason comes down to what fluoride is actually claimed to do.
The claim, not the format, decides this one
Fluoride toothpaste is grouped with sunscreen, anti-acne treatments, anti-dandruff shampoo, and antiperspirant, products that are typically regulated as drugs rather than cosmetics because of the specific physiological claim attached to them. For toothpaste, that claim is anticavity protection, sometimes paired with antigingivitis claims for products marketed to help with gum health. Both are therapeutic claims about preventing or treating a condition, tooth decay or gum disease, not cosmetic claims about appearance or surface cleaning.
This is the same underlying logic that separates a soap that only claims to cleanse from one that claims to kill bacteria, or a cream that claims to improve the appearance of stretch marks from one that claims to heal scar tissue. The ingredient or product type is secondary. What the label says the product does to the body is what classifies it.
Why this specific ingredient is the trigger
Fluoride is not just present in these toothpastes, it is the active ingredient the anticavity claim is built around. Health Canada, like most regulators, treats a substance making a disease-prevention claim as a drug ingredient, and fluoride's whole reason for being in toothpaste is exactly that: preventing dental caries. Take the anticavity claim away entirely and market a product purely as a cleaning or polishing paste for teeth with no fluoride and no cavity or gum disease claim, and you are in a genuinely different category. But that is a different product than what most people mean by "toothpaste," and it is a smaller, less common niche.
What this means practically for a maker
If your business is built around the cosmetic notification pathway, meaning you file products through the CNF process, moving into fluoride toothpaste is not an extension of that same workflow. It requires meeting drug regulatory requirements, which is a materially different process with different evidence, labeling, and market authorization expectations than a cosmetic notification.
| Product | Category | Why |
|---|---|---|
| Fluoride toothpaste with anticavity claim | Drug | Therapeutic claim to prevent tooth decay |
| Toothpaste with antigingivitis claim | Drug | Therapeutic claim about gum disease |
| Fluoride-free tooth polish, no disease claim | Potentially cosmetic, verify carefully | No therapeutic claim being made |
| Mouthwash claiming to "freshen breath" only | Likely cosmetic-type claim | Cosmetic effect, not disease treatment |
| Mouthwash claiming to "fight plaque and gingivitis" | Drug-leaning | Therapeutic disease-related claim |
That fluoride-free row is worth treating cautiously rather than as an automatic green light. The moment any disease-prevention or treatment claim attaches, whether about cavities, gingivitis, or another oral health condition, you are likely back in drug territory regardless of whether fluoride specifically is present. It is the therapeutic claim doing the work, and fluoride is just the most common ingredient carrying that particular claim in toothpaste.
If you are considering an oral care line anyway
Some makers do want to expand into oral care and are willing to take on drug-level requirements because the category is worth it to them. That is a legitimate business decision, but go in knowing it is a separate regulatory track from your cosmetic notifications, with its own evidence and process requirements that a cosmetic filing simply does not touch.
For most small-batch makers we talk to, the more common and much simpler path is staying in the cosmetic lane entirely, sticking to products like lip balms, lip scrubs, or skincare where claims stay in appearance and cleansing territory rather than disease prevention.
If you are mapping out a new product line and are not sure whether a specific formula and claim combination stays cosmetic or tips into drug territory, that classification question is worth settling before you invest in ingredients or packaging. Cosmetic Comply's screening step is built for products that are genuinely cosmetic, mapping ingredients to INCI and CAS and checking them against the Hotlist, so it is worth confirming your product belongs in that lane before running it through any filing process.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Solid Perfume in a Balm Base: How the Notification Changes
A wax-based solid perfume and an alcohol eau de toilette are both fragrance, but they notify very differently on paper.
Stretch Mark Cream and the Cosmetic Versus Drug Line
How stretch mark cream wording decides whether you are filing a cosmetic notification or stepping into drug territory.
Why Diaper Rash Cream Is a Drug and Baby Lotion Is Not
How a barrier and rash-treatment diaper cream ends up classified as a drug while a plain baby lotion stays a cosmetic.
What Extra Scrutiny Baby Lotions Face on a Notification
Why products marketed for infants draw closer ingredient review and heavier safety substantiation expectations on a Canadian filing.